Patel A, Goodman SG, Tan M, Suskin N, et al. Contemporary use of guideline-based higher potency P2Y12 receptor inhibitor therapy in patients with moderate-to-high risk non-ST-segment elevation myocardial infarction: Results from the Canadian ACS reflective II cross-sectional study. Clin Cardiol 2021 May 13. doi: 10.1002/clc.23618.
PMID: 33982795